Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
Journal of Clinical Medicine · 11.07.2023 · 12 (14) · 4624
DOI: 10.3390/jcm12144624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.07.2023. Verfasst von Katharina Knoll und 11 weiteren Autor:innen. Beteiligte Einrichtung: German Heart Centre Munich, Department of Cardiology, Technical University of Munich, 80333 Munich, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer (Germany), the Philipp Schwartz Initiative.
Abstract (Originalsprache)
Background
Wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is characterized by heart failure, conduction abnormalities and arrhythmias. The incidence of ventricular arrhythmias, particularly ventricular tachycardias (VTs), in wtATTR-CM is unclear. With the development of targeted therapies and improved overall prognosis, there is an unmet need to identify patients at high risk for VTs who might benefit from ICD therapy.
Methods
Between 2017 and 2022, 72 patients diagnosed with wtATTR-CM were prospectively evaluated for the presence of ventricular arrhythmias using a Holter ECG. VTs were defined as >3 consecutive beats with a heart rate > 100 beats per minute originating from a ventricle.
Results
The incidence of VTs was 44% (n = 32/72) in unselected wtATTR-CM patients. Patients with VT showed significantly more severe left ventricular (LV) hypertrophy (septum diameter 21 ± 2.6 vs. 19 ± 3.0 mm, p = 0.006), reduced LV ejection fraction (47 ± 8 vs. 52 ± 8%, p = 0.014) and larger left atria (32 ± 7 vs. 28 ± 6 mm2, p = 0.020), but no differences in cardiac markers such as NTproBNP and troponin. In a multivariable model, LV hypertrophy (LV mass indexed, OR = 1.02 [1.00–1.03], p = 0.031), LV end-diastolic diameter (OR = 0.85 [0.74–0.98], p = 0.021) and LV end-systolic diameter (OR = 1.19 [1.03–1.349], p = 0.092) were predictive for VT occurrence with an area under the receiver operating characteristic of 0.76 [0.65–0.87].
Conclusions
The incidence of ventricular arrhythmia in wtATTR-CM is high and is associated with an advanced stage of left ventricular disease. Further studies are needed evaluating the role of VTs in predicting sudden cardiac death and the benefit of ICD therapy in wtATTR-CM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- German Heart Centre Munich, Department of Cardiology, Technical University of Munich, 80333 Munich, Germany.
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336 Munich, Germany.
- German Heart Centre Munich, Department of Cardiovascular Surgery, Technical University of Munich, 80636 Munich, Germany.
- DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, 17475 Greifswald, Germany.
- Department of Internal Medicine B, University Medicine Greifswald, 17475 Greifswald, Germany.
ORCID-Profile: Katharina Knoll, Heribert Schunkert, Stefan Groß
Förderung
- Pfizer (Germany)
- the Philipp Schwartz Initiative
Zitieren
APA
Knoll, K., Fuchs, P., Weidmann, I., Altunkas, F., Voss, S., Lennerz, C., Kolb, C., Kessler, T., Schunkert, H., Reinhard, W., Groß, S., & Trenkwalder, T. (2023). Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy. Journal of Clinical Medicine, 12(14), 4624. https://doi.org/10.3390/jcm12144624
Vancouver
Knoll K, Fuchs P, Weidmann I, Altunkas F, Voss S, Lennerz C, et al. Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy. Journal of Clinical Medicine. 2023;12(14):4624. doi:10.3390/jcm12144624
BibTeX
@article{Knoll2023,
author = {Knoll, Katharina and Fuchs, Patrick and Weidmann, Isabel and Altunkas, Fatih and Voss, Stephanie and Lennerz, Carsten and Kolb, Christof and Kessler, Thorsten and Schunkert, Heribert and Reinhard, Wibke and Groß, Stefan and Trenkwalder, Teresa},
title = {Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {14},
pages = {4624},
doi = {10.3390/jcm12144624}
}
EUVIMED